PureTech Health (GB:PRTC) has released an update.
Seaport Therapeutics, backed by PureTech Health, has strengthened its executive team by appointing Antony Loebel, M.D., as Chief Medical Officer and Lana Gladstein, J.D., as General Counsel. Both bring significant expertise, with Loebel having successfully led CNS drug development at Sunovion Pharmaceuticals and Gladstein offering over two decades of legal experience in the biotech sector. The appointments come as Seaport advances its pipeline of novel neuropsychiatric medicines, aiming to address unmet patient needs.
For further insights into GB:PRTC stock, check out TipRanks’ Stock Analysis page.
